Details Basic Details Status Ongoing Last Updated Friday, June 23, 2023 Original Posting Date Thursday, June 22, 2023 Purpose Signal Identification Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Analytic Code Link(s) (1) Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis Result(s) (2) Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis